FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.0495
+0.0076 (+18.14%)
At Close: Apr 30, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0350 $0.0600 Tuesday, 30th Apr 2024 EVLO stock ended at $0.0495. This is 18.14% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0495 to a day high of $0.0495.
90 days $0.0350 $0.0700
52 weeks $0.0280 $13.93

Historical Evelo Biosciences Inc. prices

Date Open High Low Close Volume
Apr 30, 2024 $0.0495 $0.0495 $0.0495 $0.0495 313
Apr 29, 2024 $0.0419 $0.0495 $0.0419 $0.0419 10 204
Apr 26, 2024 $0.0435 $0.0495 $0.0410 $0.0495 31 190
Apr 25, 2024 $0.0457 $0.0457 $0.0457 $0.0457 356
Apr 24, 2024 $0.0467 $0.0484 $0.0442 $0.0442 1 256
Apr 23, 2024 $0.0450 $0.0450 $0.0425 $0.0425 1 400
Apr 22, 2024 $0.0495 $0.0495 $0.0360 $0.0436 17 551
Apr 19, 2024 $0.0495 $0.0495 $0.0360 $0.0495 3 995
Apr 18, 2024 $0.0500 $0.0500 $0.0500 $0.0500 1 552
Apr 17, 2024 $0.0499 $0.0499 $0.0440 $0.0440 61 379
Apr 16, 2024 $0.0500 $0.0500 $0.0460 $0.0460 20 504
Apr 15, 2024 $0.0419 $0.0600 $0.0410 $0.0450 14 068
Apr 12, 2024 $0.0594 $0.0594 $0.0411 $0.0505 1 069
Apr 11, 2024 $0.0419 $0.0600 $0.0410 $0.0410 35 183
Apr 10, 2024 $0.0520 $0.0520 $0.0410 $0.0410 1 843
Apr 09, 2024 $0.0438 $0.0450 $0.0410 $0.0450 4 590
Apr 08, 2024 $0.0438 $0.0438 $0.0400 $0.0419 12 407
Apr 05, 2024 $0.0449 $0.0449 $0.0350 $0.0350 44 826
Apr 04, 2024 $0.0500 $0.0500 $0.0384 $0.0400 54 862
Apr 03, 2024 $0.0500 $0.0500 $0.0450 $0.0450 12 734
Apr 02, 2024 $0.0405 $0.0500 $0.0405 $0.0500 12 857
Apr 01, 2024 $0.0500 $0.0500 $0.0420 $0.0500 100 064
Mar 28, 2024 $0.0435 $0.0550 $0.0435 $0.0450 32 383
Mar 27, 2024 $0.0400 $0.0599 $0.0400 $0.0435 14 167
Mar 26, 2024 $0.0500 $0.0550 $0.0500 $0.0500 50 314
Click to get the best stock tips daily for free!

About Evelo Biosciences Inc.

Evelo Biosciences. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated in... EVLO Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT